Overview Post-stroke Neural Plasticity With Atomoxetine Status: Completed Trial end date: 2014-12-01 Target enrollment: Participant gender: Summary This proposal evaluates the safety and effectiveness of a noradrenergic drug named atomoxetine combined with motor training to enhance cortical plasticity and improve hand function after stroke. Phase: Phase 2 Details Lead Sponsor: Lumy SawakiUniversity of KentuckyTreatments: Atomoxetine Hydrochloride